Latest Novadaq Technologies (NVDQ) Headlines
Post# of 27
Posted On: 03/10/2014 8:32:24 PM
Latest Novadaq Technologies (NVDQ) Headlines
Novadaq to Present at March Investor Healthcare Meetings
Marketwire - Mon Mar 03, 6:02AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that NOVADAQ's management will present the Company's corporate overview at two investor meetings in March.
NOVADAQ to Present at the 2014 RBC Capital Markets Healthcare Conference
Marketwire - Tue Feb 11, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present NOVADAQ's corporate overview at the 2014 RBC Capital Markets Healthcare Conference. Novadaq is scheduled to present on February 26that 8:00 am Eastern Time at The New York Palace in New York, NY.
NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Thu Feb 06, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced fourth quarter and full-year 2013 financial results. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars.
Novadaq Technologies Inc. (NVDQ) in Focus: Stock Moves 6.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 7:51AM CST
Novadaq Technologies Inc. was a big mover last session, as the company saw its shares rise a little over 6% on the day.
TauTona Group Sells 'Adipose Tissue Injector' to LifeCell
Marketwire - Mon Jan 27, 8:00AM CST
TauTona Group, a medical device incubator and investment fund focused on the rapid development of innovative medical products, today announced the sale of its Adipose Tissue Injector (aTI), a single-use, hand-held adipose tissue transfer tool, to LifeCell Corporation (LifeCell). LifeCell, along with Kinetic Concepts, Inc. and Systagenix Woundcare, form one globally diversified wound care, biologics and regenerative medicine company. Fat grafting involves moving a patient's adipose tissue from one area of the body to another. The procedure is frequently used in both aesthetic and reconstructive surgery.
NOVADAQ to Release 2013 Fourth Quarter and Full Year Financial Results on February 6, 2014 - Conference Call to Follow
Marketwire - Mon Jan 27, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically relevant imaging solutions for use in surgical and outpatient wound care procedures, will announce its fourth quarter and full year 2013 financial results before the market opening on Thursday, February 6, 2014.
Novadaq Technologies (NVDQ) in Focus: Stock Moves 3.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 8:21AM CST
Novadaq Technologies Inc. (NVDQ) was a big mover last session, as the company saw its shares rise by over 3% on the day.
4 Stocks Breaking Out on Big Volume
at The Street - Tue Jan 14, 1:17PM CST
These stocks trading on unusual volume are within range of triggering breakout trades.
Novadaq Announces Fourth Quarter 2013 Preliminary Unaudited Revenues
Marketwire - Tue Jan 14, 6:01AM CST
Novadaq(R) Technologies Inc. (NASDAQ: NVDQ)(TSX: NDQ) ("Novadaq" or the "Company"), a developer of clinically-relevant imaging solutions for use in surgical and outpatient wound care procedures, is pleased to announce preliminary unaudited revenue for the fourth quarter 2013 of approximately $10.7 million, bringing expected full year 2013 revenues to approximately $35.0 million. The preliminary unaudited quarterly numbers have not gone through review and audit procedures by the Company's external auditors and may differ from actual revenues.
Novadaq to Present at January Investor Conferences
Marketwire - Tue Dec 10, 6:01AM CST
Novadaq(R) Technologies Inc. ("Novadaq" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically-relevant imaging solutions for use in surgical and outpatient wound care procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present Novadaq's corporate overview at two investor healthcare events in January.
Medical Electronics - Global Trends, Estimates and Forecasts, 2011-2018
M2 - Fri Dec 06, 4:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7plqm/medical) has announced the addition of the "Medical Electronics - Global Trends, Estimates and Forecasts, 2011-2018" report to their offering. The Medical Electronics Market Is Expected To Reach US$372.4 Billion By 2018. Globally, medical therapeutics and imaging systems together account for approximately 52.9% of the market and are expected to support the medical electronics industry going forward. Geographical analysis shows that the highest Compounded Annual Growth Rate (CAGR) of 17.2% is anticipated from Asia-Pacific region during the analysis period, 2011-2018. Among the application sectors, monitoring & surgical systems account for the largest share of the entire market, driving a CAGR of 13.4% during the analysis period 2011-2018. Imaging Systems see as the fastest growing application with a forecast CAGR of approximately 16.9% by 2018. Along with the fast growth and rapid advancement in technology related to healthcare industry, the medical electronics expectations have increased innovatively for large numbers of incurable disease. Publication Overview The report reviews the latest medical electronics market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for electronics sector investments. The study reveals profitable investment strategies for electronics companies, business executives, product marketing managers, new business investors and many more in preferred locations. The report primarily focuses on: - Emerging Market Trends - Advancements in the Technological Space - Market Demand of the Segments (By-Region) - Key Growth Areas and Market Size - Region-Wise Demand Factor - Key Competitors Edge - Investment Strategies More than 1346 leading market players have been identified in electronics industry. 51 key companies are profiled. Applications Covered - Monitoring & Surgical Systems - Medical Therapeutics - Imaging Systems - Diagnostics Examples of Companies Mentioned - 3M Healthcare - Abbott Vascular Devices - Baxter International - Becton, Dickinson & Co. - Blueradios - C. R. Bard - Cactus Semiconductor - Cardiocomm Solutions - Cardiomems - Digirad Corporation - Medtronic - Monebo Technologies - Novadaq Technologies - Perkinelmer - Siemens Medical Solutions - St. Jude Medical - Fukuda Denshi - Heartware - IBM - Indraprastha Apollo Hospital - Panasonic Electric Works - Microports Medical - Nihon Kohden Corporation - Covidien - Dr?ger Medical Ag & Co. - F.Hoffmann-La Roche - Ge Healthcare - Philips Medical Systems - Siemens Group - Smith & Nephew For more information visit http://www.researchandmarkets.com/research/b7plqm/medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Novadaq to Present at December Investor Healthcare Events
Marketwire - Mon Nov 25, 6:01AM CST
Novadaq(R) Technologies Inc. ("Novadaq" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically-relevant imaging solutions for use in surgical and outpatient wound care procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present Novadaq's corporate overview at two investor events in December.
TauTona Group Receives FDA 510(k) Clearance and Key Patent for 'TauTona Tissue Injector'
Marketwire - Wed Nov 20, 6:01AM CST
TauTona Group, a medical device incubator and investor focused on the rapid development of innovative surgical products, today announced that the TauTona Tissue Injector (TTI), a single-use, hand-held adipose tissue transfer tool, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Fat grafting, in which a patient's adipose tissue is moved from one area of the body to another, is a frequently used technique that is growing in popularity for both aesthetic and reconstructive procedures. Earlier this year, TauTona sold its Surgical Marker technology to Novadaq(R) Technologies Inc., (NASDAQ: NVDQ) (TSX: NDQ).
Novadaq to Present at March Investor Healthcare Meetings
Marketwire - Mon Mar 03, 6:02AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that NOVADAQ's management will present the Company's corporate overview at two investor meetings in March.
NOVADAQ to Present at the 2014 RBC Capital Markets Healthcare Conference
Marketwire - Tue Feb 11, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present NOVADAQ's corporate overview at the 2014 RBC Capital Markets Healthcare Conference. Novadaq is scheduled to present on February 26that 8:00 am Eastern Time at The New York Palace in New York, NY.
NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Thu Feb 06, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced fourth quarter and full-year 2013 financial results. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars.
Novadaq Technologies Inc. (NVDQ) in Focus: Stock Moves 6.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 7:51AM CST
Novadaq Technologies Inc. was a big mover last session, as the company saw its shares rise a little over 6% on the day.
TauTona Group Sells 'Adipose Tissue Injector' to LifeCell
Marketwire - Mon Jan 27, 8:00AM CST
TauTona Group, a medical device incubator and investment fund focused on the rapid development of innovative medical products, today announced the sale of its Adipose Tissue Injector (aTI), a single-use, hand-held adipose tissue transfer tool, to LifeCell Corporation (LifeCell). LifeCell, along with Kinetic Concepts, Inc. and Systagenix Woundcare, form one globally diversified wound care, biologics and regenerative medicine company. Fat grafting involves moving a patient's adipose tissue from one area of the body to another. The procedure is frequently used in both aesthetic and reconstructive surgery.
NOVADAQ to Release 2013 Fourth Quarter and Full Year Financial Results on February 6, 2014 - Conference Call to Follow
Marketwire - Mon Jan 27, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically relevant imaging solutions for use in surgical and outpatient wound care procedures, will announce its fourth quarter and full year 2013 financial results before the market opening on Thursday, February 6, 2014.
Novadaq Technologies (NVDQ) in Focus: Stock Moves 3.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 8:21AM CST
Novadaq Technologies Inc. (NVDQ) was a big mover last session, as the company saw its shares rise by over 3% on the day.
4 Stocks Breaking Out on Big Volume
at The Street - Tue Jan 14, 1:17PM CST
These stocks trading on unusual volume are within range of triggering breakout trades.
Novadaq Announces Fourth Quarter 2013 Preliminary Unaudited Revenues
Marketwire - Tue Jan 14, 6:01AM CST
Novadaq(R) Technologies Inc. (NASDAQ: NVDQ)(TSX: NDQ) ("Novadaq" or the "Company"), a developer of clinically-relevant imaging solutions for use in surgical and outpatient wound care procedures, is pleased to announce preliminary unaudited revenue for the fourth quarter 2013 of approximately $10.7 million, bringing expected full year 2013 revenues to approximately $35.0 million. The preliminary unaudited quarterly numbers have not gone through review and audit procedures by the Company's external auditors and may differ from actual revenues.
Novadaq to Present at January Investor Conferences
Marketwire - Tue Dec 10, 6:01AM CST
Novadaq(R) Technologies Inc. ("Novadaq" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically-relevant imaging solutions for use in surgical and outpatient wound care procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present Novadaq's corporate overview at two investor healthcare events in January.
Medical Electronics - Global Trends, Estimates and Forecasts, 2011-2018
M2 - Fri Dec 06, 4:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7plqm/medical) has announced the addition of the "Medical Electronics - Global Trends, Estimates and Forecasts, 2011-2018" report to their offering. The Medical Electronics Market Is Expected To Reach US$372.4 Billion By 2018. Globally, medical therapeutics and imaging systems together account for approximately 52.9% of the market and are expected to support the medical electronics industry going forward. Geographical analysis shows that the highest Compounded Annual Growth Rate (CAGR) of 17.2% is anticipated from Asia-Pacific region during the analysis period, 2011-2018. Among the application sectors, monitoring & surgical systems account for the largest share of the entire market, driving a CAGR of 13.4% during the analysis period 2011-2018. Imaging Systems see as the fastest growing application with a forecast CAGR of approximately 16.9% by 2018. Along with the fast growth and rapid advancement in technology related to healthcare industry, the medical electronics expectations have increased innovatively for large numbers of incurable disease. Publication Overview The report reviews the latest medical electronics market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for electronics sector investments. The study reveals profitable investment strategies for electronics companies, business executives, product marketing managers, new business investors and many more in preferred locations. The report primarily focuses on: - Emerging Market Trends - Advancements in the Technological Space - Market Demand of the Segments (By-Region) - Key Growth Areas and Market Size - Region-Wise Demand Factor - Key Competitors Edge - Investment Strategies More than 1346 leading market players have been identified in electronics industry. 51 key companies are profiled. Applications Covered - Monitoring & Surgical Systems - Medical Therapeutics - Imaging Systems - Diagnostics Examples of Companies Mentioned - 3M Healthcare - Abbott Vascular Devices - Baxter International - Becton, Dickinson & Co. - Blueradios - C. R. Bard - Cactus Semiconductor - Cardiocomm Solutions - Cardiomems - Digirad Corporation - Medtronic - Monebo Technologies - Novadaq Technologies - Perkinelmer - Siemens Medical Solutions - St. Jude Medical - Fukuda Denshi - Heartware - IBM - Indraprastha Apollo Hospital - Panasonic Electric Works - Microports Medical - Nihon Kohden Corporation - Covidien - Dr?ger Medical Ag & Co. - F.Hoffmann-La Roche - Ge Healthcare - Philips Medical Systems - Siemens Group - Smith & Nephew For more information visit http://www.researchandmarkets.com/research/b7plqm/medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Novadaq to Present at December Investor Healthcare Events
Marketwire - Mon Nov 25, 6:01AM CST
Novadaq(R) Technologies Inc. ("Novadaq" or the "Company") (NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically-relevant imaging solutions for use in surgical and outpatient wound care procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present Novadaq's corporate overview at two investor events in December.
TauTona Group Receives FDA 510(k) Clearance and Key Patent for 'TauTona Tissue Injector'
Marketwire - Wed Nov 20, 6:01AM CST
TauTona Group, a medical device incubator and investor focused on the rapid development of innovative surgical products, today announced that the TauTona Tissue Injector (TTI), a single-use, hand-held adipose tissue transfer tool, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Fat grafting, in which a patient's adipose tissue is moved from one area of the body to another, is a frequently used technique that is growing in popularity for both aesthetic and reconstructive procedures. Earlier this year, TauTona sold its Surgical Marker technology to Novadaq(R) Technologies Inc., (NASDAQ: NVDQ) (TSX: NDQ).
(0)
(0)